| Drug Name | Viread (Tenofovir) |
|---|---|
| Drug Class |
Anti-viral
|
| Risk minimization type |
Healthcare provider guide
|
| Specialty (Theraputic area) |
Infectious disease
|
| Risk |
Potential renal and bone effects of TDF in children and adolescent patients with chronic hepatitis B |
| Health care provider guide |
|